Sartorius has reported 7.6 per cent increase in sales revenue in
2006 rising to €520.1m ($677.4m), due to the biotechnology
division's decision to focus on disposable systems.
US-based sterilisation system providers Steris this week announced
their fiscal 2007 third quarter results, revealing the impact of
the relocation of manufacturing capacity to Mexico and the firm's
European restructuring.
Software provider Pharsight has launched an add-on for its
graphical drug modelling method to serve in bioequivalence testing,
promising to reduce test failure.
Johnson Matthey has announced a reassuring business update ahead of
its 31 March year-end, suggesting that Adderall is the driving
force behind a recovery in its pharmaceutical materials business.
Viral vector manufacturer Lentigen has entered into a collaboration
with Wave Biotech to gain access to disposable process and
equipment expertise, which ties in with a shift in the bioprocess
manufacturing sector towards using disposable...
US-based firm Xcellerex yesterday announced it has completed the
second half of a $20m (€15.4m) financing deal, raising $11m to
speed up commercialisation of its innovative disposable
manufacturing technology for vaccines and biotherapeutics.
UK biotech company Verona Pharma has contracted fellow UK firm Onyx
to manufacture supplies of its new hay fever drug candidate for
forthcoming preclinical and clinical studies.
UK based researchers have added another dimension to
anti-counterfeiting with an alternative Raman imaging method that
is powerful enough to detect fake drugs without opening the
package.
Cardinal Health is about to sell its drug manufacturing arm to an
international private investment firm, only two months after
announcing its decision to divest the segment, while its second
quarter earnings doubled as a result.
Waters posted an 11 per cent yearly sales increase on the back of
increasing demand from the pharmaceutical industry, generic houses
and outsourcing laboratories.
Swiss chemicals firm and contract manufacturer Lonza has announced
18 per cent rise in net profit in 2006 rising to CHF 222m (€137.4),
fuelled by its strategic move into biopharmaceuticals.
Germany's Vetter Pharma-Fertigung has announced it has obtained a
manufacturing license for its new facility which will expand its
services by adding vial filling for lyophilised (freeze-dried)
products to its portfolio, in addition...
In a turbulent year, Whatman has failed to meet its projected
revenue target by 1-3 per cent and changed its management but
resolved litigation that has been hanging over the firm since 2003.
Canadian contract manufacturer QSV Biologics has signed two
manufacturing deals in as many weeks, strengthening its position in
the Phase II and III clinical supplies arena.
Agilent Technologies has signed an agreement with Groton Biosystems
to co-market measuring solutions for the pharmaceutical industry,
as the Process Analytical Technology (PAT) initiative gains
popularity among drug manufacturers...
A multi-million dollar US manufacturing contract for Acambis hinges
on whether or not the firm can satisfy the Food and Drug
Administration (FDA) that its investigational smallpox vaccine
should be approved.
US-based Blue Mountain has launched an integrated, comprehensive
software package to help life sciences companies manage their
assets, cutting out the need for individual software.
A new player has entered the pharma formulation development
services arena, offering technologies used in the food industry to
improve drug palatability.
A new Special Economic Zone (SEZ) is being created by Indian firm
JB Chemicals & Pharmaceuticals for the contract manufacturing
of active pharmaceutical ingredients (APIs), intermediates and
finished drug formulations.
The current board of directors of Helix BioPharma is being
challenged as the battle between management and one of the
company's major shareholders continues.
More and more drug makers are turning to reformulation to prolong
the lifecycle of their top sellers and protect precious revenue
from generic copies, as well as supplement dwindling pipelines.
The US Food and Drug Administration has accepted two Celsis drug
master files (DMFs) that could increase the adoption of its rapid
microbiological detection technology among pharmaceutical
manufacturers.
Russian researchers have developed a new way of sourcing a widely
used cardiovascular drug using an ecologically friendly and
water-based extraction method, which could yield three-fold cost
savings over conventional approaches.
A number of small to medium sized firms are unaware of how to use
their resources effectively to comply with hazardous waste
regulations, opening up an opportunity for online advice to address
problems facing these companies.
The power of sound waves could aid the pharmaceutical industry in
carrying out routine quality control of solid dosage forms,
according to the company behind the technology.
UK-based company ProMinent Fluid Controls has launched an on-line
sensor targeting the regulation of peracetic acid, a key
disinfectant used in the pharmaceutical industry.
PerkinElmer (PE) has continued its growth in the advanced cellular
sciences sector, with the completed acquisitions of Euroscreen
Products and Evotec Technologies.
Drug manufacturers have moved towards centralised data and
information management, following a trend to prevent human errors
and time-consuming tasks in response to increasing regulatory
requirements.
Cellexus has introduced a technology - CellMaker Lite - that
satisfies the appetite for disposable bioreactors, grows bacterial
and mammalian cells efficiently and cuts production costs.
Helix BioPharma and BioVectra have signed a deal for the
manufacture of Helix's new lung cancer drug for clinical trials - a
move that strengthens the already existing relationship between the
two Canadian firms.
Millipore has introduced a new disposable product - NovaSeal - that
ties in with a shift in the bioprocess manufacturing market to the
use of disposable assemblies to shorten production cycles for
drugs.
DSM Pharmaceuticals is showing no sign of slowing down as it
continues to invest in the expansion of its pharmaceutical
production capabilities - the latest being the completion of a
revamped sterile parenteral manufacturing plant...
Eli Lilly has signed a new agreement with drug delivery specialist
Alkermes for the manufacture of its new inhaled insulin drug - AIR
- in advance of the product's market launch.
India's drug manufacturing industry is tipped to grow 10 per cent
over the next three years as more pharma firms shift operations
there to cut costs, says a research report.
Melbourn Scientific has invested in a light obscuration particle
counter to size and count particles in liquid samples using light
microscopy, to expand the company's capacity in stability testing
and to increase throughput and...
Solid oral dose product specialist Almac Pharma has announced it
has expanded its formulation facilities located at its UK
headquarters to provide a wider range of services to pharma and
biotech companies.
India's Dishman Pharmaceuticals & Chemicals is planning to snap
up biotech and nanotech contract research organisation (CRO)
companies in Europe and in the US within drug conjugates to expand
their biologics capability.
PerkinElmer has announced its acquisition of a line of Dynamic
Mechanical Analysis (DMA) products from UK-based firm Triton
Technology in its latest move following a busy year of purchases
during 2006.
A new radio frequency identification (RFID) tag for
temperature-monitoring purposes has been developed for
pharmaceutical products during transportation, where fluctuations
in temperature can alert the logistics chain of impending...
The pharmaceutical industry's first fully portable drug
anti-counterfeiting device will be presented in Baltimore later
this month at IFPAC, the International Forum on Process Analytical
Chemistry.
